{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:07:30Z","timestamp":1784279250721,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"DOI":"10.7759\/cureus.112834","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:36:14Z","timestamp":1784277374000},"source":"Crossref","is-referenced-by-count":0,"title":["Complete Heart Block Unmasking Transthyretin Cardiac Amyloidosis: A Multimodality Imaging Case Report"],"prefix":"10.7759","author":[{"given":"Hafsa","family":"Erregui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Moujahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Loudiyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouhair","family":"Lakhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatif","family":"Benyass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk RH","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S. AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol. 2016, 68:1323-41. 10.1016\/j.jacc.2016.06.053","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg FL","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:2872-91. 10.1016\/j.jacc.2019.04.003","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez E","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G, et al.. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015, 36:2585-94. 10.1093\/eurheartj\/ehv338","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi OK","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018, 28:10-21. 10.1016\/j.tcm.2017.07.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2019.05.008","article-title":"Cardiac devices in patients with transthyretin amyloidosis: impact on functional class, left ventricular function, and mortality","volume":"16","author":"Donnellan E","year":"2019","unstructured":"Donnellan E, Wazni OM, Saliba WI, et al.. Cardiac devices in patients with transthyretin amyloidosis: impact on functional class, left ventricular function, and mortality. Heart Rhythm. 2019, 16:1651-8. 10.1016\/j.hrthm.2019.05.008","journal-title":"Heart Rhythm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore JD","year":"2018","unstructured":"Gillmore JD, Damy T, Fontana M, et al.. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018, 39:2799-806. 10.1093\/eurheartj\/ehx589","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan M","year":"2016","unstructured":"Grogan M, Scott CG, Kyle RA, et al.. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol. 2016, 68:1014-20. 10.1016\/j.jacc.2016.06.033","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytz162","article-title":"A case report of cardiac amyloidosis presenting with chronic pericardial effusion and conduction block","volume":"3","author":"John KJ","year":"2019","unstructured":"John KJ, Mishra AK, Iyyadurai R. A case report of cardiac amyloidosis presenting with chronic pericardial effusion and conduction block. Eur Heart J Case Rep. 2019, 3:1-7. 10.1093\/ehjcr\/ytz162","journal-title":"Eur Heart J Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58166","article-title":"High-grade atrioventricular block reveals rare transthyretin cardiac amyloidosis with unique hemodynamics","volume":"16","author":"Rifai ZJ","year":"2024","unstructured":"Rifai ZJ, Sukkari MH, Gilani S, Kulkarni A. High-grade atrioventricular block reveals rare transthyretin cardiac amyloidosis with unique hemodynamics. Cureus. 2024, 16:58166. 10.7759\/cureus.58166","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s44156-023-00028-7","article-title":"British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis","volume":"10","author":"Moody WE","year":"2023","unstructured":"Moody WE, Turvey-Haigh L, Knight D, et al.. British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis. Echo Res Pract. 2023, 10:13. 10.1186\/s44156-023-00028-7","journal-title":"Echo Res Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan D","year":"2012","unstructured":"Phelan D, Collier P, Thavendiranathan P, et al.. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012, 98:1442-8. 10.1136\/heartjnl-2012-302353","journal-title":"Heart"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-023-10332-3","article-title":"Advance of echocardiography in cardiac amyloidosis","volume":"28","author":"Liang S","year":"2023","unstructured":"Liang S, Liu Z, Li Q, He W, Huang H. Advance of echocardiography in cardiac amyloidosis. Heart Fail Rev. 2023, 28:1345-56. 10.1007\/s10741-023-10332-3","journal-title":"Heart Fail Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana M","year":"2015","unstructured":"Fontana M, Pica S, Reant P, et al.. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015, 132:1570-9. 10.1161\/CIRCULATIONAHA.115.016567","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia P","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, et al.. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021, 42:1554-68. 10.1093\/eurheartj\/ehab072","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer MS","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, et al.. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018, 379:1007-16. 10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana M","year":"2025","unstructured":"Fontana M, Berk JL, Gillmore JD, et al.. Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. N Engl J Med. 2025, 392:33-44. 10.1056\/NEJMoa2409134","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515646-complete-heart-block-unmasking-transthyretin-cardiac-amyloidosis-a-multimodality-imaging-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:36:15Z","timestamp":1784277375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515646-complete-heart-block-unmasking-transthyretin-cardiac-amyloidosis-a-multimodality-imaging-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.112834","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}